HealthcarePress Releases

Drug of Abuse Testing Market Size is Forecasted to Reach USD 10.7 Billion by 2030 Says Precedence Research

Share This Article

The drug of abuse testing market demand stood at 5.8 billion in 2020 and is forecast to reach 10.7 billion by 2030, growing at a healthy CAGR of 6.4% until FY2030, according to a 2021 study by Precedence Research, the Canada-based market Insight Company.

The report contains 150+ pages with detailed analysis and it is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit).

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1313

Market Report Scope

Report Highlights Details
Market Size in 2020 US$ 5.8 Billion
Growth Rate CAGR of 6.4% from 2021 to 2030
Market Size US$ 10.7 Billion by 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Drug Type, Sample Type, End User, Region

Drug of abuse testing services is used to detect whether an individual consumed any drugs. This test is conducted by testing various sample such as urine, blood, hair, and saliva. The growing consumption of drugs among the population is the primary driver of the global drug of abuse testing market. Further, various government initiatives to control the use of drugs among the youth is exponentially driving the market growth across the globe.

According to the United Nations Office on Drugs and Crime, around 246 million people used illicit drug and the population aged between 15 and 64 years, in 2013.According to UNDOC, around 40% of the global people who inject drugs are infected with HIV. Hence, the rising prevalence of HIV is a major factor that encourages the restriction on drug use, thereby propelling the growth of the global drug of abuse testing market.

Crucial factors accountable for market growth are:

  • Growing usage of drugs like marijuana, cocaine among the youth
  • Growing cases of drug use disorder
  • Rising number deaths related to drug overdose
  • Government initiatives to tackle drug abuse
  • Technological advancements and development of cost-effective test kits
  • Rising prevalence of HIV among the drug injectors

Report Highlights

  • By drug type, the marijuana/cannabis segment led the global drug of abuse market with remarkable revenue share in 2020. This is attributed to the increased consumption and popularity of the marijuana. Moreover, in countries like India, it is easily available to the drug users due to the lack of proper administrative control on the illegal drug suppliers.
  • By sample type, the urine segment led the global drug of abuse market with remarkable revenue share in 2020. This is because the urinalysis is the most accurate and feasible test. Kidney helps to remove wastes and other toxic materials from the blood through urine and hence urinalysis is much more effective.
  • By end user, the workplaces segment led the global drug of abuse market with remarkable revenue share in 2020. The employers need to know about the health of their employ. A drug user frequently switches job and highly unproductive and inefficient in his work. Hence, the workplaces need to conduct drug of abuse tests.

Market Dynamics

Drivers – The market is significantly driven by the demand from the private employers and growing abuse of prescribed drugs. According to the National Institute of Drug Abuse, over 50 million people used prescription drugs such as pain relievers for non-medical purposes. Therefore, growing uses of prescription drugs for non-medical use is boosting the growth of the market.

Restraints – The low awareness, inadequate healthcare infrastructure, and low financial capabilities in underdeveloped and developing regions may hamper the growth of the market. Moreover, inefficiency of the government to tackle drug abuse issues have resulted in the increased consumption of alcohol among the teenagers.

Opportunities – The development of low-cost and disposable testing devices may propel the market growth in the upcoming years. Further, the development on-the-spot testing kits shows rapid and reliable results is expected to gain traction.

Challenges – The high cost of the testing equipment and low penetration of research laboratories in the underdeveloped markets is a major challenge to the drug of abuse market players.

Regional Snapshots

North America dominated the global drug of abuse testing market. This is attributed to the highest consumption of drugs such as heroin, cocaine, cannabis, and alcohol in the region. Moreover government initiatives like the implementation Patients and Communities Act to counter the problem of drug abuse is a major factor influencing the growth of the market across the region. According to the National Survey on Drug Use and Health Report, over 500,000 teenagers in US were suffering from drug use disorders in 2018. Hence the rising use of drugs among the teenagers is a major threat to the national interests that propels the growth of the drug of abuse testing market.Further, the presence of numerous key market players in the region and their strategical developments fueled the growth of the drug of abuse market in this region.

Asia Pacific is expected to be the fastest-growing region. According to the Australian National Council – Asia Pacific Report, Cambodia has become the leading source of cannabis the globe. Major economy like China has taken an initiative to set up a huge network of drug treatment centers across the nation. Around 74.4% of the Hong Kong drug users prefers heroin and around 80% of the HIV cases in Indonesia is directly associated with the injection drug use. The Asia Pacific is becoming a major market for the illicit drug traders due to the failure of government to tackle this situation. Therefore, Asia Pacific has a huge growth potential for the drug of abuse testing market.

Competition Landscape

In the final section of the research report, Precedence Research provided the global drug of abuse testing market structure and a detailed competition landscape to provide a dashboard view of key players operating in the drug of abuse testing market along with their business strategies to report audiences. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the value chain of the market.

Some of the major players in the drug of abuse testing market include:

  • Danaher Corporation
  • LabCorp
  • Abbott Laboratories
  • Quest Diagnostics, Inc.
  • Cordant Health Solutions
  • DrugScan
  • Legacy Medical Services
  • Mayo Clinic Laboratories
  • LGC Group
  • Precision Diagnostics

Market Segmentation

By Drug Type

  • Alcohol
  • Cocaine
  • Marijuana/Cannabis
  • LSD
  • Opioids
  • Others

By Sample Type

  • Urine
  • Saliva
  • Blood
  • Others

By End User

  • Workplaces
  • Criminal Justice Systems
  • Hospitals
  • Research Labs

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us recognize financial information, structure of the market participants and industry competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
  • In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

Why should you invest in this report?

If you are aiming to enter the global drug of abuse testing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for drug of abuse testing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1313

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Drug of Abuse Testing Market, By Drug

7.1. Drug of Abuse Testing Market, by Drug Type, 2021-2030

7.1.1. Alcohol

7.1.1.1. Market Revenue and Forecast (2019-2030)

7.1.2. Cocaine

7.1.2.1. Market Revenue and Forecast (2019-2030)

7.1.3. Marijuana/Cannabis

7.1.3.1. Market Revenue and Forecast (2019-2030)

7.1.4. LSD

7.1.4.1. Market Revenue and Forecast (2019-2030)

7.1.5. Opioids

7.1.5.1. Market Revenue and Forecast (2019-2030)

7.1.6. Others

7.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 8. Global Drug of Abuse Testing Market, By End User

8.1. Drug of Abuse Testing Market, by End User, 2021-2030

8.1.1. Workplaces

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Criminal Justice Systems

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Hospitals

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Research Labs

8.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Drug of Abuse Testing Market, By Sample 

9.1. Drug of Abuse Testing Market, by Sample, 2021-2030

9.1.1. Urine

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Saliva

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Blood

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Drug of Abuse Testing Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Drug (2019-2030)

10.1.2. Market Revenue and Forecast, by End User (2019-2030)

10.1.3. Market Revenue and Forecast, by Sample (2019-2030)

10.1.4. U.S.

10.1.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.1.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.1.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.1.5. Rest of North America

10.1.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.1.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.1.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2.4. UK

10.2.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2.5. Germany

10.2.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2.6. France

10.2.6.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.6.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.6.3. Market Revenue and Forecast, by Sample (2019-2030)

10.2.7. Rest of Europe

10.2.7.1. Market Revenue and Forecast, by Drug (2019-2030)

10.2.7.2. Market Revenue and Forecast, by End User (2019-2030)

10.2.7.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3.4. India

10.3.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3.5. China

10.3.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3.6. Japan

10.3.6.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.6.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.6.3. Market Revenue and Forecast, by Sample (2019-2030)

10.3.7. Rest of APAC

10.3.7.1. Market Revenue and Forecast, by Drug (2019-2030)

10.3.7.2. Market Revenue and Forecast, by End User (2019-2030)

10.3.7.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4.4. GCC

10.4.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4.5. North Africa

10.4.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4.6. South Africa

10.4.6.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.6.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.6.3. Market Revenue and Forecast, by Sample (2019-2030)

10.4.7. Rest of MEA

10.4.7.1. Market Revenue and Forecast, by Drug (2019-2030)

10.4.7.2. Market Revenue and Forecast, by End User (2019-2030)

10.4.7.3. Market Revenue and Forecast, by Sample (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.5.3. Market Revenue and Forecast, by Sample (2019-2030)

10.5.4. Brazil

10.5.4.1. Market Revenue and Forecast, by Drug (2019-2030)

10.5.4.2. Market Revenue and Forecast, by End User (2019-2030)

10.5.4.3. Market Revenue and Forecast, by Sample (2019-2030)

10.5.5. Rest of LATAM

10.5.5.1. Market Revenue and Forecast, by Drug (2019-2030)

10.5.5.2. Market Revenue and Forecast, by End User (2019-2030)

10.5.5.3. Market Revenue and Forecast, by Sample (2019-2030)

Chapter 11. Company Profiles

11.1. Danaher Corporation

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. LabCorp

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Abbott Laboratories

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Quest Diagnostics, Inc.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Cordant Health Solutions

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. DrugScan

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Legacy Medical Services

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Mayo Clinic Laboratories

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. LGC Group

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Precision Diagnostics

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1313

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Follow us on LinkedIn | Twitter | Facebook

Show More

Market Stats News

Market Stats News is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services, we aim at connecting an organization’s goal with lucrative prospects globally.

Related Articles

Back to top button